Get the Stockscreener App
6.61
1.69%
0.11
Capsovision Inc stock is traded at $6.61, with a volume of 185.81K.
It is up +1.69% in the last 24 hours and up +3.93% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
See More
Previous Close:
$6.50
Open:
$6.55
24h Volume:
185.81K
Relative Volume:
0.77
Market Cap:
$330.26M
Revenue:
$13.56M
Net Income/Loss:
$-26.97M
P/E Ratio:
-11.51
EPS:
-0.5742
Net Cash Flow:
$-24.04M
1W Performance:
-4.06%
1M Performance:
+3.93%
6M Performance:
-37.35%
1Y Performance:
+0.00%
1-Day Range:
$6.41
$6.725
1-Week Range:
$6.335
$7.40
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.61 | 330.26M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
CapsoVision prices $27.5M IPO - MSN
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CapsoVision Inc (CV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CapsoVision Inc (CV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CV | CapsoVision, Inc. Common Stock Insider Trading - Quiver Quantitative
CapsoVision shareholders re-elect directors and approve auditor at annual meeting - Investing.com
CapsoVision Stockholders Reelect Directors, Ratify 2026 Auditor - TipRanks
CapsoVision Inc. (CV) Declines 2.5% as Bearish Pressure Builds Near Key SupportCumulative Volume - newsline.com
CapsoVision Inc. (CV) Q1 2026 Earnings: EPS Miss Exceeds Estimates, Stock DeclinesPost-Earnings Reaction - newsline.com
CapsoVision Inc. (CV) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
CapsoVision Inc. (CV) Faces Selling Pressure as Shares Slide Over 4.6%Triangle Correction - newsline.com
CV Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue PhaseTax Rate Impact - newsline.com
CapsoVision Inc. (CV) Q1 2026 Earnings: EPS Miss Widens Losses, Stock DeclinesRevenue Inflection Point - newsline.com
CapsoVision (CV) awards 158,078 options to Head of Global Sales - Stock Titan
CV News | CAPSOVISION INC (NASDAQ:CV) - ChartMill
CV Q1 2026 Earnings: EPS Misses Estimates as Losses WidenBasic EPS Analysis - newsline.com
CV Q1 2026 Earnings: EPS Misses Estimates but Stock Gains 1.95%EPS Consistency Score - newsline.com
CapsoVision Inc. (CV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CapsoVision Inc. (CV) Edges Higher Amid Consolidation – Key Levels to WatchReversal Setup Alerts - The Legal Advocate
CV Q1 2026 Earnings: EPS Misses Estimates Amidst Market HeadwindsEarnings Momentum Score - newsline.com
CapsoVision (CV) Edges Higher, Consolidating Between Key LevelsKAMA Signal - newsline.com
CV Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesNet Profit Margin - The Legal Advocate
CapsoVision Stock Edges Higher as FDA AI Decision Becomes the Real Test - Bez Kabli
CV Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesGuidance vs Actual - thelegaladvocate.com
CV Q1 2026 Earnings: EPS Misses Estimates Amidst Challenging QuarterInterim Report - newsline.com
CV Q1 2026 Earnings: EPS Misses Estimates by 12%, Stock Declines Nearly 2%Pre-Earnings Setup - newsline.com
CapsoVision (CV) Q1 2026 Earnings: EPS Miss Raises Concerns Amid Operational UncertaintyProfitability Analysis - Newser
CapsoVision Inc. (CV) Gains 1.77% as Shares Test Key Resistance Near $7.23Community Pattern Alerts - Newser
CapsoVision Inc. (CV) Advances 1.18% as Price Moves Toward ResistanceMedian Line - The Legal Advocate
CapsoVision (CV) Q1 2026 Miss: What Went WrongConsensus Beat Rate - Newser
CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026 - MSN
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
U.S. Smart Pills Market to Reach USD 619.10 Million by 2033 as - openPR.com
CapsoVision, Inc. (CV) AI-Powered Stock Analysis - Meyka
CapsoVision Reports Stable Q1 Revenue and Expands AI Medical Pipeline - HarianBasis.co
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 - Investing.com UK
Benchmark reiterates Speculative Buy on CapsoVision stock at $10 By Investing.com - Investing.com South Africa
CapsoVision Q1 Earnings Call Highlights - sharewise.com
CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading - ChartMill
CAPSOVISION ($CV) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings call transcript: CapsoVision misses Q1 2026 EPS forecast, stock rises - Investing.com
Transcript: CapsoVision Q1 2026 Earnings Conference Call - Benzinga
CapsoVision Q1 2026 Earnings Call Transcript - MarketBeat
CapsoVision Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):